Tapewire

Nasdaq · USD

TMCI

TREACE MEDICAL CONCEPTS, INC.

Export transactions ↓
Tapewire entity
5943
SEC CIK
0001630627
Parsed reports
290

Last 12 months

Inside the activity.

14 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202660
Jun 202650
Jul 202600
Aug 202630
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Scanlan Sean F.Chief Innovation Officer
GrantCommon Stock 65,025 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001589 · doc4.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 97,209

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 96,070 RSUs.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Treace John T.Director · Chief Executive Offer · 10% owner
GrantCommon Stock 178,325 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001590 · doc4.xml · nonDerivative · entry 1

Treace John T. · CIK 0001856380 · Director · Chief Executive Offer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,800,180

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 203,731 restricted stock units.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Hair MarkChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 104,600 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-24-001591 · doc4.xml · derivative · entry 3

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,600

Underlying: Stock Option (Right to Buy) · 104,600 shares

Expires 2034-01-10

F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Hair MarkChief Financial Officer
GrantCommon Stock 92,875 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001591 · doc4.xml · nonDerivative · entry 1

Hair Mark · CIK 0001725070 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,810

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 147,662 RSUs.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Berutti AaronSr. VP, Sales
GrantStock Option (Right to Buy) · Derivative 73,200 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-24-001593 · doc4.xml · derivative · entry 2

Berutti Aaron · CIK 0001871334 · Sr. VP, Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,200

Underlying: Stock Option (Right to Buy) · 73,200 shares

Expires 2034-01-10

F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Berutti AaronSr. VP, Sales
GrantCommon Stock 65,025 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001593 · doc4.xml · nonDerivative · entry 1

Berutti Aaron · CIK 0001871334 · Sr. VP, Sales

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,867

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 103,787 RSUs.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Elder Scot Michael*See "Remarks"
GrantStock Option (Right to Buy) · Derivative 69,050 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-24-001592 · doc4.xml · derivative · entry 2

Elder Scot Michael · CIK 0001916619 · *See "Remarks"

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,050

Underlying: Stock Option (Right to Buy) · 69,050 shares

Expires 2034-01-10

F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
January 10, 2024 Filed Jan 13, 2024 02:00 UTC
Elder Scot Michael*See "Remarks"
GrantCommon Stock 61,300 $0.00 $0.00
Disclosure

SEC source: 0001209191-24-001592 · doc4.xml · nonDerivative · entry 1

Elder Scot Michael · CIK 0001916619 · *See "Remarks"

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,210

F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date.

F2 · balance_after: Includes 105,932 RSUs.

Read SEC document
November 02, 2023 Filed Nov 4, 2023 01:00 UTC
Scanlan Sean F.Chief Innovation Officer
Tax withholdingCommon Stock 211 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-054433 · doc4.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,184

F1 · balance_after: Includes 31,045 RSUs.

Read SEC document
November 02, 2023 Filed Nov 4, 2023 01:00 UTC
Elder Scot Michael*See "Remarks"
Tax withholdingCommon Stock 609 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-054434 · doc4.xml · nonDerivative · entry 1

Elder Scot Michael · CIK 0001916619 · *See "Remarks"

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,910

F1 · balance_after: Includes 44,632 RSUs.

Read SEC document
October 03, 2023 Filed Oct 6, 2023 01:00 UTC
Elder Scot Michael*See "Remarks"
Tax withholdingCommon Stock 402 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-052266 · doc4.xml · nonDerivative · entry 1

Elder Scot Michael · CIK 0001916619 · *See "Remarks"

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,519

F1 · balance_after: Includes 45,241 RSUs.

Read SEC document
June 05, 2023 Filed Jun 8, 2023 16:28 UTC
BAYS F BARRYFormer Director
SaleCommon Stock 1,042,318 $26.51 $27,631,850.18
Disclosure

SEC source: 0001209191-23-035400 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Former Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Read SEC document
June 02, 2023 Filed Jun 8, 2023 16:28 UTC
BAYS F BARRYFormer Director
SaleCommon Stock 48,503 $26.51 $1,285,814.53
Disclosure

SEC source: 0001209191-23-035400 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Former Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,042,318

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC
Hanna BetsyDirector
GrantStock Option (Right to Buy) · Derivative 6,305 $0.00 Strike: $26.34 $0.00
Disclosure

SEC source: 0001209191-23-032353 · doc4.xml · derivative · entry 2

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,305

Underlying: Common Stock · 6,305 shares

Expires 2033-05-23

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC
Hanna BetsyDirector
GrantCommon Stock 2,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-032353 · doc4.xml · nonDerivative · entry 1

Hanna Betsy · CIK 0001885957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,235

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 3,940 RSUs.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC GrantStock Option (Right to Buy) · Derivative 6,305 $0.00 Strike: $26.34 $0.00
Disclosure

SEC source: 0001209191-23-032352 · doc4.xml · derivative · entry 2

Berry Lance A · CIK 0001478716 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,305

Underlying: Common Stock · 6,305 shares

Expires 2033-05-23

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC GrantCommon Stock 2,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-032352 · doc4.xml · nonDerivative · entry 1

Berry Lance A · CIK 0001478716 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,585

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 5,585 RSUs.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC GrantStock Option (Right to Buy) · Derivative 6,305 $0.00 Strike: $26.34 $0.00
Disclosure

SEC source: 0001209191-23-032354 · doc4.xml · derivative · entry 4

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,305

Underlying: Common Stock · 6,305 shares

Expires 2033-05-23

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC GrantCommon Stock 2,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-032354 · doc4.xml · nonDerivative · entry 1

BAKEWELL JOHN K · CIK 0001183553 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,048

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the issuer's Common Stock issuable upon settlement of the RSUs until the earlier of (a) a change in control, (b) the Reporting Person's separation of service to the Issuer, or (c) the fifth anniversary of the RSU's grant date.

F2 · balance_after: Includes 2,753 RSUs.

Read SEC document
May 23, 2023 Filed May 25, 2023 21:00 UTC GrantStock Option (Right to Buy) · Derivative 6,305 $0.00 Strike: $26.34 $0.00
Disclosure

SEC source: 0001209191-23-032351 · doc4.xml · derivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,305

Underlying: Common Stock · 6,305 shares

Expires 2033-05-23

F4 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 23, 2023 Filed May 25, 2023 21:00 UTC GrantCommon Stock 2,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-032351 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 907,753

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · price: Includes 2,753 RSUs.

F3 · balance_after: Includes 2,753 RSUs.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC GrantStock Option (Right to Buy) · Derivative 6,305 $0.00 Strike: $26.34 $0.00
Disclosure

SEC source: 0001209191-23-032355 · doc4.xml · derivative · entry 2

HAMILTON LAWRENCE W · CIK 0001326586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,305

Underlying: Common Stock · 6,305 shares

Expires 2033-05-23

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC GrantStock Option (Right to Buy) · Derivative 6,305 $0.00 Strike: $26.34 $0.00
Disclosure

SEC source: 0001209191-23-032350 · doc4.xml · derivative · entry 2

Kiernan Jane E · CIK 0001379171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,305

Underlying: Common Stock · 6,305 shares

Expires 2033-05-23

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC GrantCommon Stock 2,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-032350 · doc4.xml · nonDerivative · entry 1

Kiernan Jane E · CIK 0001379171 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,585

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 5,585 RSUs.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC
Jain DeeptiDirector
GrantStock Option (Right to Buy) · Derivative 6,305 $0.00 Strike: $26.34 $0.00
Disclosure

SEC source: 0001209191-23-032349 · doc4.xml · derivative · entry 2

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,305

Underlying: Common Stock · 6,305 shares

Expires 2033-05-23

F3 · derivative.exercise_date: The stock option will vest in 12 substantially equal monthly installments, commencing on June 23, 2023, such that the stock option will be fully vested and exercisable on the earlier of (a) May 23, 2024, or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
May 23, 2023 Filed May 26, 2023 01:00 UTC
Jain DeeptiDirector
GrantCommon Stock 2,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-032349 · doc4.xml · nonDerivative · entry 1

Jain Deepti · CIK 0001840203 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,235

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.

F2 · balance_after: Includes 3,940 RSUs.

Read SEC document
May 16, 2023 Filed May 19, 2023 01:00 UTC
Scanlan Sean F.Chief Innovation Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $0.10 $0.00
Disclosure

SEC source: 0001209191-23-030857 · doc4.xml · derivative · entry 3

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,750

Underlying: Common Stock · 25,000 shares

Expires 2024-12-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The stock option vested in equal annual installments over 4 years, commencing on December 15, 2015 with the last installment vesting on December 15, 2018.

Read SEC document
May 16, 2023 Filed May 19, 2023 01:00 UTC
Scanlan Sean F.Chief Innovation Officer
SaleCommon Stock 25,000 $25.44 $635,977.50
Disclosure

SEC source: 0001209191-23-030857 · doc4.xml · nonDerivative · entry 2

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,395

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0600 to $25.8000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 31,256 RSUs.

Read SEC document
May 16, 2023 Filed May 19, 2023 01:00 UTC
Scanlan Sean F.Chief Innovation Officer
Exercise / conversionCommon Stock 25,000 $0.10 $2,500.00
Disclosure

SEC source: 0001209191-23-030857 · doc4.xml · nonDerivative · entry 1

Scanlan Sean F. · CIK 0001856371 · Chief Innovation Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,395

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 31,256 RSUs.

Read SEC document
May 01, 2023 Filed May 2, 2023 21:00 UTC SaleCommon Stock 2,360 $25.91 $61,148.31
Disclosure

SEC source: 0001209191-23-026796 · doc4.xml · nonDerivative · entry 3

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 861,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5400 to $26.1500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 01, 2023 Filed May 2, 2023 21:00 UTC SaleCommon Stock 7,640 $25.04 $191,282.68
Disclosure

SEC source: 0001209191-23-026796 · doc4.xml · nonDerivative · entry 2

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 863,801

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.5400 to $25.5000 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 28, 2023 Filed May 2, 2023 21:00 UTC SaleCommon Stock 40,000 $25.01 $1,000,264.00
Disclosure

SEC source: 0001209191-23-026796 · doc4.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 871,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.4100 to $25.3050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 27, 2023 Filed Apr 28, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 11,600 $25.35 $294,031.00
Disclosure

SEC source: 0001209191-23-026167 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,090,821

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.1500 to $25.6950 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 26, 2023 Filed Apr 28, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 16,204 $25.55 $414,012.20
Disclosure

SEC source: 0001209191-23-026167 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,102,421

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.4400 to $25.7850 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 12, 2023 Filed Apr 13, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 36,370 $26.12 $950,104.42
Disclosure

SEC source: 0001209191-23-024260 · doc4.xml · nonDerivative · entry 3

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,118,625

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.8400 to $26.5050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 11, 2023 Filed Apr 13, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 5,026 $27.28 $137,108.27
Disclosure

SEC source: 0001209191-23-024260 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,154,995

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $27.1500 to $27.5700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 11, 2023 Filed Apr 13, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 44,764 $26.28 $1,176,286.01
Disclosure

SEC source: 0001209191-23-024260 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,160,021

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0100 to $26.9700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
April 06, 2023 Filed Apr 10, 2023 21:00 UTC SaleCommon Stock 4,043 $26.00 $105,121.23
Disclosure

SEC source: 0001209191-23-023948 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 905,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.0000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 21:00 UTC SaleCommon Stock 15,756 $26.00 $409,667.03
Disclosure

SEC source: 0001209191-23-023543 · doc4.xml · nonDerivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 909,043

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 2,295 RSUs.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 21:00 UTC SaleCommon Stock 201 $26.00 $5,226.00
Disclosure

SEC source: 0001209191-23-023543 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 924,799

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 2,295 RSUs.

Read SEC document
March 31, 2023 Filed Mar 31, 2023 21:00 UTC SaleCommon Stock 95,000 $25.36 $2,409,029.00
Disclosure

SEC source: 0001209191-23-021956 · doc4.xml · nonDerivative · entry 2

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 925,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0000 to $25.9050 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
March 30, 2023 Filed Mar 31, 2023 21:00 UTC SaleCommon Stock 50,000 $25.86 $1,293,170.00
Disclosure

SEC source: 0001209191-23-021955 · doc4.xml · nonDerivative · entry 1

TREACE JAMES T · CIK 0001185191 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 911,441

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5100 to $26.0700 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 30, 2023 Filed Mar 31, 2023 21:00 UTC SaleCommon Stock 38,498 $26.00 $1,000,998.05
Disclosure

SEC source: 0001209191-23-021956 · doc4.xml · nonDerivative · entry 1

MOTT RICHARD W · CIK 0001210226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,020,000

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $26.000 to $26.0200 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 2,295 RSUs.

Read SEC document
March 29, 2023 Filed Mar 30, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 32,457 $25.28 $820,425.33
Disclosure

SEC source: 0001209191-23-021741 · doc4.xml · nonDerivative · entry 2

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,204,785

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.0900 to $25.5600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 28, 2023 Filed Mar 30, 2023 21:00 UTC
BAYS F BARRYDirector
SaleCommon Stock 26,241 $25.02 $656,649.54
Disclosure

SEC source: 0001209191-23-021741 · doc4.xml · nonDerivative · entry 1

BAYS F BARRY · CIK 0001183554 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,237,242

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.8800 to $25.1600 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 23, 2023 Filed May 26, 2023 01:00 UTC GrantCommon Stock 2,753 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-032355 · doc4.xml · nonDerivative · entry 1

HAMILTON LAWRENCE W · CIK 0001326586 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,048

F1 · shares: Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 23, 2024 or (b) the date of the 2024 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer.

F2 · balance_after: Includes 2,753 RSUs.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 21:00 UTC
Owens Daniel E.Chief Human Resources Officer
Exercise / conversionStock Option Right to Buy · Derivative 6,250 $0.00 Strike: $7.03 $0.00
Disclosure

SEC source: 0001209191-23-019944 · doc4.xml · derivative · entry 3

Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 176,375

Underlying: Stock Option Right to Buy · 6,250 shares

Expires 2031-02-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 21:00 UTC
Owens Daniel E.Chief Human Resources Officer
SaleCommon Stock 6,250 $22.87 $142,955.63
Disclosure

SEC source: 0001209191-23-019944 · doc4.xml · nonDerivative · entry 2

Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,914

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.6600 to $23.3900 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: Includes 25,650 RSUs.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 21:00 UTC
Owens Daniel E.Chief Human Resources Officer
Exercise / conversionCommon Stock 6,250 $7.03 $43,925.00
Disclosure

SEC source: 0001209191-23-019944 · doc4.xml · nonDerivative · entry 1

Owens Daniel E. · CIK 0001858105 · Chief Human Resources Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · balance_after: Includes 25,650 RSUs.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 21:00 UTC SaleCommon Stock 50,000 $23.03 $1,151,665.00
Disclosure

SEC source: 0001209191-23-019943 · doc4.xml · nonDerivative · entry 1

TIMBIE THOMAS E · CIK 0001188309 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Thomas E. Timbie and Pamela F. Timbie, TTEEs of the Thomas E. Timbie Rev Trust u/a dtd May 2, 2001

Disclosed balance after: 1,149,069

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.7500 to $23.4300 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.